Revenue Growth (YoY)

Teladoc Health's revenue growth of -2.5% year-over-year (YoY) means the company's sales actually shrank compared to the same period last year, a decline that signals weaker demand or pricing power.

Among Healthcare sector peers, this figure sits well below the sector median of 6.2% and places Teladoc in the 15th percentile, indicating the vast majority of competitors grew faster. However, because only a single quarter of data is provided, no trend can be assessed; the YoY and quarter-over-quarter changes are both listed as not available, so you cannot determine whether the decline is accelerating or improving. The combination of a negative growth level with an unknown trend introduces uncertainty — investors face risk if the contraction continues, but there is no evidence of momentum either way. This metric directly contradicts the overall neutral verdict on the stock; a revenue decline of -2.5% against a sector growing at 6.2% typically raises concern, not neutrality, and suggests the underlying business is underperforming relative to its peers.

Frequently Asked Questions

Closest Sector Peers